Tag: "tenofovir" at medical news
New Zealand’s Pharmac Subsidies Two More HIV Drug
...ive health manager Eamonn Smythe: "In New Zealand, tenofovir
was approved by (medicines regulator) Medsafe in November 2005, but HIV-positive patients have been unable to access it sooner due to delays in Pharmac and manufacturer Gilead reaching a suitable funding compromise." Smythe reports HIV as a comple...
Merck Announces Plans for Licensing Atripla Widely in Developing World
...ingle tablet containing a daily dose of efavirenz, tenofovir
and emtricitabine, will be priced at $613 a year f... western Europe, and Gilead, the license holder of tenofovir
and emtricitabine. In contrast to Gilead's policy with tenofovir, where the company has granted volu...
Once-daily Nevirapine Has More Side-effects Than Twice-daily Dose
... to once-daily nevirapine (400mg), ddI (400mg) and tenofovir
(300mg). In this study, adverse events leading to treatment discontinuation were more common in the once-daily group. After 48 weeks, three patients (4%) who continued twice-daily dosing stopped therapy versus twelve individuals (14%) who switched to...
Cipla launches 3-in-1 AIDS drug in India
...t. // The three anti-HIV drugs efavirenz 600 mg, tenofovir
300 mg and emtricitabine 200mg comprise the drug Viraday.Viraday, one tablet of which alone effectively treats a HIV infected person, eliminates the need for 3 separate medicines. This drug has some advantages like, it is less burdensome and it can b...
Study Compares First-Line Drug Therapies For Treating HIV
...ine, plus their choice of stavudine, zidovudine or tenofovir
disoproxil fumarate. The researchers found all three of the treatment regimens were potent, producing substantial increases in CD4+ T cell counts and decreases in HIV viral load. After 96 weeks of treatment, 89 percent of the participants randomize...
AIDS Sufferers Protest against Proposed Patent for Tenofovir
...he drug has been available in India as the generic tenofovir
disoproxil fumarate since last year. Some demons... many of us living with HIV/AIDS, newer drugs like tenofovir
offer a new hope of continuing treatment. With patents interfering with our lives, we have no choice...